Skip to main content
Signal8

Durgam Suresh K.

SEC insider (Form 3/4/5 filer). CIK 0001829958. EVP, Chief Medical Officer at Intra-Cellular Therapies, Inc. (ITCI). 12 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2025. Located in BEDMINSTER, NJ.

Companies Durgam Suresh K. has filed insider reports for

  • Intra-Cellular Therapies, Inc. (ITCI): Officer, EVP, Chief Medical Officer
Durgam Suresh K. profile photo

Durgam Suresh K.

CIK: 0001829958

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (25.0%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)5 (41.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Intra-Cellular Therapies, Inc. logo
ITCI

Intra-Cellular Therapies, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Award

    Performance Stock Units

    Direct
    8.7K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Award

    Performance Stock Units

    Direct
    13.1K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Disposition
    Direct
    42.9K shares at avg. $132.00$5.7M
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 10, 2025
    Exercise
    Direct
    7.3K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 10, 2025
    Tax Payment
    Direct
    3.1K shares at avg. $131.24$409K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 6, 2025
    Exercise
    Direct
    13.1K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 6, 2025
    Tax Payment
    Direct
    5.6K shares at avg. $131.19$731K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 1, 2025
    Tax Payment
    Direct
    3.7K shares at avg. $128.20$475K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 1, 2025
    Exercise
    Direct
    8.7K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Feb 3, 2025
    Award

    Restricted Stock Units

    Direct
    24.6K shares-

1-10 of 12